CD274 and neoplasm: Therefore, we sought to determine the potential synergistic therapeutic effect of 2-BP and PD-1/L1 inhibitor in poorly immunogenic Panc 02 tumor model, characterized by a low proportion of tumor infiltrating lymphocytes with resistance to anti-PD-1/PD-L1 therapy [50].